Overview
Holly Bridge practices in Oxford, United Kingdom. Bridge is rated as an Elite expert by MediFind in the treatment of Anton Syndrome. Their top areas of expertise are Anophthalmia Plus Syndrome, Anton Syndrome, Charles Bonnet Syndrome, and Opsoclonus-Myoclonus Syndrome.
Their clinical research consists of co-authoring 95 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 8 articles in the study of Anton Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Anophthalmia Plus Syndrome
- Anton SyndromeBridge isElite. Learn about Anton Syndrome.
- Distinguished
- Charles Bonnet SyndromeBridge isDistinguished. Learn about Charles Bonnet Syndrome.
- Opsoclonus-Myoclonus SyndromeBridge isDistinguished. Learn about Opsoclonus-Myoclonus Syndrome.
- Advanced
- AgnosiaBridge isAdvanced. Learn about Agnosia.
- Cone-Rod DystrophyBridge isAdvanced. Learn about Cone-Rod Dystrophy.
- Experienced
- AmblyopiaBridge isExperienced. Learn about Amblyopia.
- Brown SyndromeBridge isExperienced. Learn about Brown Syndrome.
- ChoroideremiaBridge isExperienced. Learn about Choroideremia.
- Ganglion CystBridge isExperienced. Learn about Ganglion Cyst.
- Late-Onset Retinal DegenerationBridge isExperienced. Learn about Late-Onset Retinal Degeneration.
- Retinopathy Pigmentary Mental Retardation